Innovation Health Services (@ihscardiac) 's Twitter Profile
Innovation Health Services

@ihscardiac

Cardiac CT and MRI rapid interpretation for acute chest pain and stable outpatient scans. Nationwide network of Level II and III cardiologists and radiologists.

ID: 1095394581858770944

linkhttp://ihsmd.org calendar_today12-02-2019 18:49:54

74 Tweet

86 Followers

296 Following

Innovation Health Services (@ihscardiac) 's Twitter Profile Photo

CBCCT Eligibility Changes Coming in 2021 - minimum is going up to 250 cases to achieve Level 2. If you haven't attained yet, consider doing so this year via one of our in-person courses. apca.org/certifications… ihsmd.org/further-cardio… #cardiotwitter #cardiacimaging #cvimaging

Heart_SCCT (@heart_scct) 's Twitter Profile Photo

Participants from around the globe have gathered to attend the #SCCTWinter2020 meeting in Tel Aviv as it kicks off today with the two pre-courses; CTA Academy and the Technologist/Radiographer course. #YesCCT #CardioTwitter

Participants from around the globe have gathered to attend the #SCCTWinter2020 meeting in Tel Aviv as it kicks off today with the two pre-courses; CTA Academy and the Technologist/Radiographer course. #YesCCT #CardioTwitter
Innovation Health Services (@ihscardiac) 's Twitter Profile Photo

Interested to see the outcome of the FORECAST trial and use of FFRCT: "....will assess the clinical and economic outcomes of using FFRCT as the primary test to evaluate patients presenting with stable chest pain." #cardiotwitter #cvimaging #cardiacimaging ncbi.nlm.nih.gov/pubmed/3193217…

Innovation Health Services (@ihscardiac) 's Twitter Profile Photo

AI algorithm can spot LVEF from 15 seconds of ECG data cardiovascularbusiness.com/topics/cardiov… #cardiotwitter #cardiacimaging #cvimaging

Innovation Health Services (@ihscardiac) 's Twitter Profile Photo

Risks associated with iodine contrast have been overstated. In the absence of AKI, contrast is safe when eGFR >30. No prophylaxis with normal saline or reduction in contrast volume is necessary for these patients. pubs.rsna.org/doi/10.1148/ra… #cardiology #cardionews #cardiotwitter

Matthew Budoff MD (@budoffmd) 's Twitter Profile Photo

Nice Review of CCTA for acute chest pain, jby Suraj Dahal, a Class IA indication with 7 prospective trials showing superiority over nuclear, hs troponins, treadmill, standard of care and CCTA still comes out faster, less expensive and superior. pubmed.ncbi.nlm.nih.gov/36511943/

Holly (@hollymorgs) 's Twitter Profile Photo

Disruptive data from REVIVED viability analysis! ❌️ Amount of hibernating myocardium NOT associated with prognosis /LV recovery ❌️ Viability testing does NOT identify patients who benefit from PCI However ➡️ scar burden closely correlates with prognosis /LV recovery

Disruptive data from <a href="/REVIVED_BCIS2/">REVIVED</a> viability analysis!
❌️ Amount of hibernating myocardium NOT associated with prognosis /LV recovery 
❌️ Viability testing does NOT identify patients who benefit from PCI

However ➡️ scar burden closely correlates with prognosis /LV recovery
Innovation Health Services (@ihscardiac) 's Twitter Profile Photo

TARGET: CCTA + On-site CT-FFR - ⏬ in Cath with No CAD or CAD w/o PCI vs SOC (Predom stress ECG); ↔️ MACE/Cost - Would love to know: 1) Turn around time? 2) Rejection rate? 3) Vendor compatibility? #ACC23 #ACCImaging #WCC2023 Brian with the Good Dictations Ron Blankstein Matthew Budoff MD Quynh Truong

TARGET: CCTA + On-site CT-FFR
- ⏬ in Cath with No CAD or CAD w/o PCI vs SOC (Predom stress ECG); ↔️ MACE/Cost
- Would love to know:
1) Turn around time?
2) Rejection rate?
3) Vendor compatibility? 
#ACC23 #ACCImaging #WCC2023 <a href="/ghoshhajra/">Brian with the Good Dictations</a> <a href="/RonBlankstein/">Ron Blankstein</a> <a href="/BudoffMd/">Matthew Budoff MD</a> <a href="/cardioQT/">Quynh Truong</a>
Innovation Health Services (@ihscardiac) 's Twitter Profile Photo

Improving access, decreasing scan times, refining protocols, resonating with your C-suite were all brilliantly discussed by Lauren A. Baldassarre, MD, FACC, FSCCT, FSCMR @HeartDocSubha 👏 IHS is committed to meet the growing demand and need for cMRI #ACCImaging #whyCMR Emilio Fentanes Dr. Purvi Parwani

Improving access, decreasing scan times, refining protocols, resonating with your C-suite were all brilliantly discussed by <a href="/CardioOnc_MR_CT/">Lauren A. Baldassarre, MD, FACC, FSCCT, FSCMR</a>  @HeartDocSubha 👏 IHS is committed to meet the growing demand and need for cMRI  #ACCImaging  #whyCMR  <a href="/Fentanes_MD/">Emilio Fentanes</a> <a href="/purviparwani/">Dr. Purvi Parwani</a>
NEJM (@nejm) 's Twitter Profile Photo

Patients with evidence of microplastics and nanoplastics in carotid artery plaque, as compared with patients without, had a greater risk of adverse cardiovascular events at 34 months of follow-up. Read the full article: nej.md/3IrM6T8

Patients with evidence of microplastics and nanoplastics in carotid artery plaque, as compared with patients without, had a greater risk of adverse cardiovascular events at 34 months of follow-up. Read the full article: nej.md/3IrM6T8